Cambridge Cognition Gets £2.2M Neurodegenerative Disease Trial Contract

T-Reuters
Sep 01, 2022

Cambridge Cognition Holdings PLC :Cambridge Cognition - £2.2M Neurodegenerative Disease Trial Contract.Cambridge Cognition Holdings Plc -Gets £2.2 Million Contract Providing Cognitive Assessments And Electronic Diaries For A Neurodegenerative Disease Trial.Cambridge Cognition Holdings Plc - Revenue From Contract Is Expected Over Next Two Financial Years.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10